The insider sales are too small to signal material bearishness. Monitor for any further insider selling or clinical updates on Danon disease, which is the next major catalyst. The stock's low price near $3.60 may attract speculative interest ahead of H2 2026 data.
Price Chart
Executive Summary
Rocket Pharmaceuticals CEO Gaurav Shah sold $10K worth of shares and another insider sold $68K, totaling $78K in open-market sales over a 7-day window. This follows the Q1 earnings report showing a narrowed net loss and the $180M PRV monetization, but the stock trades near $3.60 with a $393M market cap. The insider sales are modest (0.02% of market cap) and likely driven by routine portfolio management rather than a bearish signal, especially given the recent positive catalyst.
Key Financial Metrics
Key Facts
- CEO Gaurav Shah sold 2,728 shares at $3.606 for ~$10K on May 13, 2026.
- Sarbani Chaudhuri sold 17,600 shares at $3.84 for ~$68K on May 7, 2026.
- Total insider sales of $78K represent ~0.02% of RCKT's $393M market cap.
- Q1 2026 net loss improved to -$47.6M from -$61.3M YoY; KRESLADI approved and PRV monetized for $180M.
- Cash runway extended into Q2 2028; Danon disease Phase 2 update expected H2 2026.
Financial Impact
Insider sales of $78K are trivial relative to $393M market cap (0.02%).
Risk Factors
- Further insider selling could erode confidence if it accelerates.
- Danon disease trial failure would be a major setback.
- Cash burn remains high despite extended runway.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RCKT-1778790001885 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $3.41 $3.35 | ▼ −1.76% | ▼ −3.89% | $2.54 (−25.66%) |
Aug 20, 2026 6w ago | Insider Cluster | $3.48 $3.62 | ▲ +4.02% | ▲ +2.91% | $2.54 (−27.16%) |
Aug 17, 2026 6w ago | Insider Cluster | $3.34 $3.78 | ▲ +13.17% | ▲ +13.37% | $2.54 (−24.10%) |
Aug 13, 2026 7w ago | Insider Cluster | $3.34 $3.48 | ▲ +4.04% | ▲ +6.01% | $2.54 (−24.10%) |
Aug 10, 2026 7w ago | 8-K | $3.50 $3.34 | ▼ −4.57% | ▼ −4.17% | $2.54 (−27.57%) |
Aug 3, 2026 8w ago | 8-K | $3.41 $3.64 | ▲ +6.74% | ▲ +4.72% | $2.54 (−25.66%) |
Jun 30, 2026 13w ago | 8-K | $3.52 $4.07 | ▲ +15.63% | ▲ +15.36% | $2.54 (−27.98%) |
Jun 12, 2026 16w ago | 8-K | $2.75 $3.35 | ▲ +21.82% | ▲ +21.15% | $2.54 (−7.82%) |
May 26, 2026 18w ago | Insider Cluster | $2.99 $2.92 | ▼ −2.34% | ▼ −2.81% | $2.54 (−15.22%) |
May 7, 2026 21w ago | Insider Cluster | $3.25 $2.96 | ▼ −8.92% | ▼ −9.89% | $2.54 (−22.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access